Co-Diagnostics, Inc.
CODX
$0.3421
-$0.0179-4.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -27.84% | 28.43% | |||
| Total Other Revenue | -100.00% | -82.60% | |||
| Total Revenue | -76.71% | -75.87% | |||
| Cost of Revenue | -14.22% | 40.22% | |||
| Gross Profit | -130.75% | -85.94% | |||
| SG&A Expenses | 24.13% | 28.12% | |||
| Depreciation & Amortization | 1.68% | 3.81% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.85% | 5.22% | |||
| Operating Income | -16.34% | -33.27% | |||
| Income Before Tax | -14.11% | -27.65% | |||
| Income Tax Expenses | -136.94% | 7.77% | |||
| Earnings from Continuing Operations | -13.76% | -27.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.76% | -27.60% | |||
| EBIT | -16.34% | -33.27% | |||
| EBITDA | -16.86% | -34.63% | |||
| EPS Basic | -12.36% | -26.04% | |||
| Normalized Basic EPS | -17.39% | -32.70% | |||
| EPS Diluted | -12.13% | -26.83% | |||
| Normalized Diluted EPS | -17.39% | -32.70% | |||
| Average Basic Shares Outstanding | 1.25% | 1.23% | |||
| Average Diluted Shares Outstanding | 1.25% | 1.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||